Close Menu
Home » Stratify Genomics Taps PWNHealth to Offer Prostate Cancer Risk Test Online

Stratify Genomics Taps PWNHealth to Offer Prostate Cancer Risk Test Online

Nov 25, 2019
|
staff reporter

NEW YORK – Stratify Genomics said on Monday that it has partnered with PWNHealth to offer Stratify's prostate cancer genetic risk test directly to consumers with medical oversight.

Specifically, Stratify and PWNHealth will provide clinical oversight and patient support for Stratify's Prompt Personal Genetic Score (PGS) through the Stratify online portal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

What's Popular?

In Cancer

  1. CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

  2. Natera Sues ArcherDx for Infringement of New Target Amplification Patent

  3. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

  4. Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry

    Premium

  5. Saga, Servier Sign Liquid Biopsy Services Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.